Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
1 New TAVR system linked to key improvements | Radial artery grafts vs. saphenous vein grafts for CABG
Wednesday, November 30, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic’s newest self-expanding TAVR system linked to improved performance

Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 

READ MORE >
Medtronic launches Evolut FX TAVR system aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s newest self-expanding TAVR system linked to improved performance

Share on Twitter Share on Facebook Share on Linkedin
Medtronic launches Evolut FX TAVR system aortic stenosis.
Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 
READ MORE >

Radial artery grafts vs. saphenous vein grafts for CABG: Does one outperform the other?

The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona. 

READ MORE >
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
Share on Twitter Share on Facebook Share on Linkedin

Radial artery grafts vs. saphenous vein grafts for CABG: Does one outperform the other?

Share on Twitter Share on Facebook Share on Linkedin
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona. 
READ MORE >

Featured Articles

Edwards shares new one-year data on transcatheter tricuspid valve replacement

The new findings, presented at the PCR London Valves 2022 conference, focused on mortality and heart failure hospitalization rates. 

READ MORE >
Edwards Lifesciences Corporation has shared new one-year data on the safety and effectiveness of its Evoque transcatheter tricuspid valve replacement (TTVR) system among patients with tricuspid regurgitation (TR)
Share on Twitter Share on Facebook Share on Linkedin

Edwards shares new one-year data on transcatheter tricuspid valve replacement

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences Corporation has shared new one-year data on the safety and effectiveness of its Evoque transcatheter tricuspid valve replacement (TTVR) system among patients with tricuspid regurgitation (TR)
The new findings, presented at the PCR London Valves 2022 conference, focused on mortality and heart failure hospitalization rates. 
READ MORE >

Adding extra salt to your food at the table associated with a greater risk of CVD, heart failure

Yes, even a little additional salt can make a big impact on a person's cardiovascular health. The full analysis was published in the Journal of the American College of Cardiology.

READ MORE >
Salt substitutes are associated with a reduced risk of high blood pressure without increasing the risk of low blood pressure, according to new findings published in the Journal of the American College of Cardiology.[1]
Share on Twitter Share on Facebook Share on Linkedin

Adding extra salt to your food at the table associated with a greater risk of CVD, heart failure

Share on Twitter Share on Facebook Share on Linkedin
Salt substitutes are associated with a reduced risk of high blood pressure without increasing the risk of low blood pressure, according to new findings published in the Journal of the American College of Cardiology.[1]
Yes, even a little additional salt can make a big impact on a person's cardiovascular health. The full analysis was published in the Journal of the American College of Cardiology.
READ MORE >

Surgeons make history, become first in world to implant Abiomed’s new heart pump for right heart failure

Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. 

READ MORE >
Abiomed’s Impella RP Flex with SmartAssist heart pump has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of acute right heart failure for up to 14 days.
Share on Twitter Share on Facebook Share on Linkedin

Surgeons make history, become first in world to implant Abiomed’s new heart pump for right heart failure

Share on Twitter Share on Facebook Share on Linkedin
Abiomed’s Impella RP Flex with SmartAssist heart pump has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of acute right heart failure for up to 14 days.
Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. 
READ MORE >

In Case You Missed It

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.

READ MORE >
Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension
Share on Twitter Share on Facebook Share on Linkedin

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Share on Twitter Share on Facebook Share on Linkedin
Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension
Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.
READ MORE >

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

READ MORE >
Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Share on Twitter Share on Facebook Share on Linkedin
Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.
Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 
READ MORE >

In Other News

New AI model calculates risk of heart attack or stroke using a single X-ray

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago. 

READ MORE >
Chest X-ray. Using an explainable artificial intelligence (AI) model, researchers were recently able to accomplish highly accurate labeling on large datasets of publicly available chest radiograph X-rays.. 
Share on Twitter Share on Facebook Share on Linkedin

New AI model calculates risk of heart attack or stroke using a single X-ray

Share on Twitter Share on Facebook Share on Linkedin
Chest X-ray. Using an explainable artificial intelligence (AI) model, researchers were recently able to accomplish highly accurate labeling on large datasets of publicly available chest radiograph X-rays.. 
“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago. 
READ MORE >

Boston Scientific to acquire Apollo Endosurgery for $615M

Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific to acquire Apollo Endosurgery for $615M

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme